Daniel Lochner
Chief Financial Officer, Oyster Point Pharma, Inc.
Companies
- Tectonic Therapeutic, Inc.Chief financial officer Jun 24, 2024 to now1
- Oyster Point Pharma, Inc.Chief financial officer Oct 30, 2019 to Jan 4, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tectonic Therapeutic, Inc. TECX58,544 shares3$1.3M at $21.36Mar 4, 2026
- Oyster Point Pharma, Inc.0 shares4Jan 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 4, 2026Granted 26,500 shares of Tectonic Therapeutic, Inc.3
- Feb 10, 2026Bought 6,000 shares at $21.61 of Tectonic Therapeutic, Inc.5
- Feb 4, 2026Shares withheld for tax 2,077 shares at $23.22 of Tectonic Therapeutic, Inc.6
- Sep 25, 2025Granted 5,430 shares of Tectonic Therapeutic, Inc.7
- Feb 5, 2025Bought 4,617 shares at $54.14 of Tectonic Therapeutic, Inc.8
- Feb 4, 2025Granted 18,074 shares of Tectonic Therapeutic, Inc.9
- Jan 3, 2023Returned to company 20,236 shares of Oyster Point Pharma, Inc.4
- Jan 3, 2023U 56,289 shares of Oyster Point Pharma, Inc.4
- Dec 1, 2022Shares withheld for tax 3,258 shares at $11.20 of Oyster Point Pharma, Inc.10
- Jan 29, 2022Shares withheld for tax 938 shares at $11.70 of Oyster Point Pharma, Inc.4
- Jan 9, 2022Granted 19,500 shares of Oyster Point Pharma, Inc.11
- Nov 1, 2021Exercised options 8,590 shares at $11.51 of Oyster Point Pharma, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 11, 2026
- 6SEC EDGARForm 4 filed Feb 10, 2026
- 7SEC EDGARForm 4 filed Sep 29, 2025
- 8SEC EDGARForm 4 filed Feb 7, 2025
- 9SEC EDGARForm 4 filed Feb 6, 2025
- 10SEC EDGARForm 4 filed Dec 6, 2022
- 11SEC EDGARForm 4 filed Jan 11, 2022
- 12SEC EDGARForm 4 filed Nov 2, 2021